Another “Holy Grail” being touted for diagnosis of high-risk prostate cancer: an update

We have now been able to track down a link to detailed information about the article by Yu et al. referred to in yesterday’s commentary under the same heading. … READ MORE …

Another “Holy Grail” being touted for diagnosis of high-risk prostate cancer

Another new test — this time (supposedly) reported on-line in the American Journal of Pathology (and scheduled for publication in the June issue of that journal) — has suggested that monitoring genetic variation may be helpful in predicting risk from specific types of prostate cancer. If one is to believe the report in today’s Pittsburgh Post-Gazette, the new test ‘could represent “the Holy Grail of prostate cancer” by specifying from the start whether aggressive treatment is necessary’ … READ MORE …